Integrated Stress Response Signatures Drive Monocyte Dysfunction in GBA1- and LRRK2-Linked Parkinson's Disease
Daniele MatteiiD, Erica Brophy, Mikaela Rosén, Oriol Narcis Majos, Aloysius DomingoiD, Elena Meijia, Claudia De SanctisiD, Beomjin JangiD, Tarek Khashan, Mengxi Yang, Deborah RaymondiD, Casey YoungiD, Jack HumphreyiD, Elisa NavarroiD, Amanda AllaniD, Katherine Leaver, Viktoriya Katsnelson, Alexander Chung, Benjamin Muller, Matthew Swan, Vicki ShankeriD, Mariel Pullman, Adina H. WiseiD, Roberto Ortega, Kelly AstudilloiD, , Towfique RajiD
Abstract
Monocytes are increasingly implicated in Parkinsons disease (PD) pathogenesis, with idiopathic cases showing mitochondrial and lysosomal dysfunction. However, the impact of PD-associated mutations on monocytes remains unclear. To address this, we investigated transcriptomic and functional disturbances in peripheral monocytes from patients with GBA1- and LRRK2-associated PD and idiopathic PD. Transcriptomic data revealed shared and mutation-specific signatures, including those related to immune dysregulation, and consistent defects in lysosomal and mitochondrial pathways. Network and pathway analyses further uncovered downregulation in protein translation and enrichment of integrated stress response (ISR) signatures, alongside aberrant expression of genes linked to ER stress, proteostasis, mitophagy and type-I interferon signaling. These data suggest that monocyte immune dysfunction in PD may be, at least in part, a consequence of impaired proteostasis, organelle stress and maladaptive ISR activation. We further interrogated these signatures in functional assays in patient-derived macrophages, which revealed impaired mitochondrial potential, proteolysosomal dysfunction, and defective phagocytosis. Our findings define convergent molecular and functional abnormalities in genetic PD monocytes, implicating proteostasis failure and maladaptive ISR activation as upstream drivers of immune dysfunction, highlighting novel targetable pathways for therapeutic intervention.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discordant transcriptional signatures of mitochondrial genes in Parkinson's disease human myeloid cells
Elisa Navarro, Evan Udine, … Towfique Raj·Nature AgingPeer-reviewed·Sep 14, 2021
- Transcriptome deregulation of peripheral monocytes in GBA-related Parkinson's disease
Giulietta Maria Riboldi, Ricardo A. Vialle, … Towfique Raj·Molecular NeurodegenerationPeer-reviewed·Aug 17, 2022
- LRRK2 G2019S variant is associated with transcriptional changes in Parkinson's disease human myeloid cells under proinflammatory environment
Elisa Navarro, Anastasia G. Efthymiou, … Towfique Raj·Journal of NeuroinflammationPeer-reviewed·Aug 8, 2026
- Myeloid PINK1 represses mtDNA release and immune signaling that impacts neuronal pathology in patient-derived idiopathic PD models
Sherilyn Junelle Recinto, Adam MacDonald, … Jo Anne Stratton·bioRxiv·Jan 8, 2026
- Pathologic α-Synuclein Species Activate LRRK2 in Pro-Inflammatory Monocyte and Macrophage Responses
Enquan Xu, Ravindra Boddu, … Andrew B. West·bioRxiv·May 4, 2020
- Pathogenic mutations in LRRK2 sequester Rab8a to damaged lysosomes and regulate transferrin-mediated iron uptake in microglia
A. Mamais, N. Landeck, … M. R. Cookson·bioRxiv·Jul 27, 2020